Boehringer Ingelheim Global Capability Center (Mumbai)

"Boehringer Ingelheim, headquartered in Ingelheim am Rhein, Germany, is one of the world's largest privately held pharmaceutical companies with over €23 billion in revenue (2025) and approximately 53,000 employees globally. Founded in 1885, the company operates across human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. Its India operations date back to 2003, with the Mumbai office serving as the commercial and clinical operations hub supporting the company's presence across respiratory, cardiovascular, oncology, and immunology therapeutic areas.

The Mumbai centre functions as a value creator delivering clinical operations, commercial operations, IT services, and data analytics for Boehringer Ingelheim's global pharmaceutical business. The centre has grown from approximately 300 employees in 2023 to 672 in 2026, reflecting steady expansion in its clinical and commercial capabilities. The technology environment includes SAP, Salesforce, and enterprise analytics platforms supporting the company's worldwide research, development, and commercialisation activities.

Boehringer Ingelheim's India operations have been recognised as a Great Place to Work and among the Best Companies for Women in India, reflecting the company's commitment to inclusive workplace practices. While smaller than many pharmaceutical GCCs in India, the centre plays an important role in Boehringer Ingelheim's global operations, supporting the company's mission of transforming lives through innovative therapies in areas of high unmet medical need."

Parent Enterprise Overview